GlassScriptPhysician profile
Carrie Ma
NPI 1760162234
$2,285.08
in general payments reported to CMS, 2019-2025
16 companies · $847 in 2025
The $847 reported for 2025 was more than what 83% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $127 · 2024: $1,311 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,285.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $433.66 | 2024-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $402.56 | 2023-2025 | |
| Amgen INC. | $241.01 | 2024-2025 | Evenity, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $227.53 | 2024-2025 | Farxiga, Airsupra, Breztri |
| Ibsa Pharma INC. | $171.90 | 2024 | Licart, Flector, Tirosint |
| Exact Sciences Corporation | $139.44 | 2023-2024 | Cologuard Collection Kit |
| Agios Pharmaceuticals, INC. | $137.42 | 2024-2025 | Pyrukynd |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $130.57 | 2023-2024 | Trulance |
| Regeneron Healthcare Solutions, INC. | $92.25 | 2023-2024 | Dupixent |
| Pfizer INC. | $81.94 | 2023-2025 | |
| Lilly USA, LLC | $49.93 | 2024-2025 | Jardiance |
| Viatris Specialty LLC | $45.62 | 2025 | Yupelri |
| Verona Pharma, INC. | $39.67 | 2025 | Ohtuvayre |
| Shield Therapeutics INC | $36.47 | 2025 | |
| Esperion Therapeutics, INC. | $34.38 | 2024-2025 | Nexletol |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $20.73 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Ma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.